IQVIA Holdings, Inc. (IQV)
IQV moved a median of +0.02% 30 minutes after news, and +0.02% by the close. How IQV actually reacts to news — the realized, point-in-time move the market made, measured across 329 labeled events over the last three years with zero look-ahead.
IQV’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.02% | 47% | 329 |
| 30-min | +0.02% | 51% | 329 |
| 60-min | +0.10% | 57% | 329 |
| to close | +0.02% | 51% | 325 |
| Middle 50% of IQV reactions | -0.61% to +0.58% |
|---|---|
| Median reaction (30-min) | +0.02% |
| Measured reactions | 329 |
Half of all IQVIA Holdings, Inc. news events land between -0.61% and +0.58% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How IQV reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 35 | +0.12% | 51% | -0.43% |
| Analyst downgrades | 36 | -0.03% | 44% | +0.30% |
| Coverage initiations | 25 | +0.19% | 52% | +0.23% |
| Rating reiterations | 132 | -0.02% | 47% | +0.03% |
| Price-target raises | 31 | +0.04% | 55% | -0.07% |
| Price-target cuts | 44 | +0.23% | 59% | +0.35% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how IQV ranks against every other measured name →
That’s how IQV usually reacts — get an email when it moves on news →Email me when IQV moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to IQV's baseline. Nothing else.
Recent IQV events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| IQVIA Selects Veeva Clinical Operations Applications | Press release | Business Wire | +0.43% | -1.07% | |
| IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions | Press release | Business Wire | +0.55% | +1.15% | |
| IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes | Press release | Business Wire | +0.55% | +1.15% | |
| IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 | Press release | Business Wire | -0.06% | -0.41% | |
| Form 8-K IQVIA HOLDINGS INC. For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | +1.76% | +3.21% | |
| Form 8-K IQVIA HOLDINGS INC. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -0.03% | +1.07% | |
| IQVIA Announces Offering of Senior Notes | Press release | Business Wire | -0.28% | -0.05% | |
| IQVIA Announces Pricing of Senior Notes | Press release | Business Wire | -0.03% | +1.07% | |
| IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster | Press release | Business Wire | -0.77% | +0.47% | |
| IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare | Press release | Business Wire | -0.04% | +0.46% | |
| IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year | Press release | Business Wire | -0.67% | +1.18% | |
| IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group | Press release | Business Wire | -0.25% | -1.77% | |
| IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery | Press release | Business Wire | +1.02% | +1.91% | |
| Form 10-Q IQVIA HOLDINGS INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.47% | +2.39% | |
| Form 8-K IQVIA HOLDINGS INC. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +3.18% | +2.54% | |
| IQVIA Reports Second-Quarter 2026 Results | Press release | Business Wire | +3.18% | +2.54% | |
| IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States | Press release | Business Wire | -0.06% | +0.41% | |
| IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 | Press release | Business Wire | +0.00% | +2.31% | |
| Form 8-K IQVIA HOLDINGS INC. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | -1.08% | +0.17% | |
| Form 8-K IQVIA HOLDINGS INC. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.86% | -2.06% | |
| IQVIA Announces Pricing of Senior Notes | Press release | Business Wire | -0.02% | -0.02% | |
| Form 8-K IQVIA HOLDINGS INC. For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | -1.24% | +0.95% | |
| IQVIA Announces Offering of Senior Notes | Press release | Business Wire | +0.52% | +2.59% | |
| IQVIA CEO to Speak at Jefferies Global Healthcare Conference | Press release | Business Wire | +1.96% | +1.26% | |
| IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities | Press release | Business Wire | +0.87% | -0.93% | |
| Form 8-K IQVIA HOLDINGS INC. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | -2.14% | -2.04% | |
| IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization | Press release | Business Wire | -2.14% | -2.04% | |
| IQVIA CFO to Speak at Bank of America Health Care Conference 2026 | Press release | Business Wire | +1.71% | +0.18% | |
| Form 10-Q IQVIA HOLDINGS INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.06% | -2.13% | |
| Form 8-K IQVIA HOLDINGS INC. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | +1.31% | +9.41% | |
| IQVIA Reports First-Quarter 2026 Results | Press release | Business Wire | +1.31% | +9.41% | |
| Form 8-K IQVIA HOLDINGS INC. For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | -0.22% | +0.59% | |
| Form S-8 IQVIA HOLDINGS INC. | SEC filing · Form S-8 | SEC EDGAR | -0.22% | +0.59% | |
| IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 | Press release | Business Wire | -0.08% | -3.39% | |
| IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences | Press release | Business Wire | +0.47% | +1.06% | |
| IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference | Press release | Business Wire | +0.97% | +1.86% | |
| IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference | Press release | Business Wire | +0.97% | +1.86% | |
| Form ARS IQVIA HOLDINGS INC. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.11% | -0.31% | |
| Form DEF 14A IQVIA HOLDINGS INC. For: Apr 23 | SEC filing · Form DEF | SEC EDGAR | +1.11% | -0.31% | |
| Form DEFA14A IQVIA HOLDINGS INC. | SEC filing · Form DEFA14A | SEC EDGAR | +1.11% | -0.31% | |
| IQVIA Releases its 2025 Sustainability Report | Press release | Business Wire | +1.11% | -0.31% | |
| IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities | Press release | Business Wire | -1.12% | -2.48% | |
| IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day | Press release | Business Wire | -0.25% | +0.18% | |
| Form 10-K IQVIA HOLDINGS INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.81% | -1.06% | |
| IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions | Press release | Business Wire | +0.89% | -5.05% | |
| Form 8-K IQVIA HOLDINGS INC. For: Feb 05 | SEC filing · Form 8-K | SEC EDGAR | -3.71% | -8.80% | |
| IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance | Press release | Business Wire | -3.71% | -8.80% | |
| IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration | Press release | Business Wire | -1.35% | -1.37% | |
| IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year | Press release | Business Wire | +0.03% | -1.34% | |
| IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 | Press release | Business Wire | +0.94% | +2.32% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the IQV section they belong to.
Where else IQV is measured.
IQV earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | 330 | +0.15% | 56% |
| BG MEDICINE INC (BGMD) | 329 | 0.00% | 39% |
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is IQVIA Holdings, Inc.'s median reaction calculated?
Every labeled IQV news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 329 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of IQV's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does IQV's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.